Affected Entity |
Phenotypic quality |
Occurs in |
Occurs at |
Evidence |
Observed in |
Drugs/Inhibitors |
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania amazonensis
|
No drug identifiers listed for this gene.
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 09/08/82. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; . |
References: |
2392684
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
amastigote (BTO:0000062)
|
inferred from bioassay (ECO:0000094)
|
Leishmania amazonensis
|
No drug identifiers listed for this gene.
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 09/08/82. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; . |
References: |
2392684
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania mexicana
|
79195
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
2044859
|
morphology (PATO:0000051)
|
abnormal (PATO:0000460)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from visible phenotype (ECO:0000176)
|
Leishmania mexicana
|
79195
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
2044859
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
amastigote (BTO:0000062)
|
inferred from bioassay (ECO:0000094)
|
Leishmania mexicana
|
79195
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
2044859
|
cell differentiation (GO:0030154)
|
disrupted (PATO:0001507)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania mexicana
|
79195
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
chemical inhibition with antimicrotubule agents leads to disrupted differentiation from promastigote to amastigote of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
2044859
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania amazonensis
|
586034
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 95480-32-3. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
8468004
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania amazonensis
|
13316
39854
79195
544264
551075
552236
554547
555991
557331
559236
559237
559604
561797
562909
564379
564831
568817
568820
568821
569525
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
7818612
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania major
|
39854
250338
536202
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 121-50-6; Drug: 394-25-2; Drug: 14371-82-5; Drug: 22227-59-4; Drug: 174824-16-9; Drug: 176177-41-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
8849257
|
microtubule polymerization (GO:0046785)
|
decreased (PATO:0000468)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from specific protein inhibition (ECO:0000020)
|
Leishmania amazonensis
|
2976
8265
27599
67873
86876
250338
327961
371083
376038
543486
543487
559148
560712
572272
575226
588233
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 16037-91-5. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin and in live cells; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
10029309
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania amazonensis
|
2976
8265
27599
67873
86876
250338
327961
371083
376038
543486
543487
559148
560712
572272
575226
588233
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 16037-91-5. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
10029309
|
microtubule polymerization (GO:0046785)
|
increased (PATO:0000470)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania donovani
|
2976
8265
559148
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
chemical inhibition with microtubule stabilising agent forces mictotubule formation in live cells and interrupts cell cycle; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
10427726
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania donovani
|
2976
8265
559148
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
chemical inhibition with microtubule stabilising agent forces mictotubule formation in live cells and interrupts cell cycle; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
10427726
|
growth (GO:0040007)
|
drug insensitive (PATO:0000528)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania donovani
|
2976
8265
559148
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
chemical inhibition with microtubule stabilising agent generated cell line resistant to drug with a MDR phenotype; reversible with Ca2+-channel blocker verapamil; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
10427727
|
growth (GO:0040007)
|
drug insensitive (PATO:0000528)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania infantum
|
37094
39854
79195
250338
551075
562909
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
10546848
|
microtubule polymerization (GO:0046785)
|
decreased (PATO:0000468)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from specific protein inhibition (ECO:0000020)
|
Leishmania donovani
|
2976
8265
80107
559148
576689
576690
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 313705-89-4; Drug: 157207-90-4. chemical inhibition with antimicrotubule agents leads to abnormal cell morphology, cell division, mitosis, organelle localization & organization, and slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
11071278
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania donovani
|
2976
8265
80107
559148
576689
576690
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 313705-89-4; Drug: 157207-90-4. chemical inhibition with antimicrotubule agents leads to abnormal cell morphology, cell division, mitosis, organelle localization & organization, and slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
11071278
|
cytokinesis (GO:0000910)
|
discontinuous (PATO:0000690)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from visible phenotype (ECO:0000176)
|
Leishmania donovani
|
2976
8265
80107
559148
576689
576690
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 313705-89-4; Drug: 157207-90-4. chemical inhibition with antimicrotubule agents leads to abnormal cell morphology, cell division, mitosis, organelle localization & organization, and slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
11071278
|
mitotic sister chromatid segregation (GO:0000070)
|
discontinuous (PATO:0000690)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from visible phenotype (ECO:0000176)
|
Leishmania donovani
|
2976
8265
80107
559148
576689
576690
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 313705-89-4; Drug: 157207-90-4. chemical inhibition with antimicrotubule agents leads to abnormal cell morphology, cell division, mitosis, organelle localization & organization, and slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
11071278
|
organelle localization (GO:0051640)
|
discontinuous (PATO:0000690)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from visible phenotype (ECO:0000176)
|
Leishmania donovani
|
2976
8265
80107
559148
576689
576690
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 313705-89-4; Drug: 157207-90-4. chemical inhibition with antimicrotubule agents leads to abnormal cell morphology, cell division, mitosis, organelle localization & organization, and slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
11071278
|
morphology (PATO:0000051)
|
abnormal (PATO:0000460)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from visible phenotype (ECO:0000176)
|
Leishmania donovani
|
2976
8265
80107
559148
576689
576690
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 313705-89-4; Drug: 157207-90-4. chemical inhibition with antimicrotubule agents leads to abnormal cell morphology, cell division, mitosis, organelle localization & organization, and slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
11071278
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from anti-sense experiment (ECO:0000018)
|
Leishmania donovani
|
No drug identifiers listed for this gene.
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Genetic disruption of the beta-tubulin gene product via anti-sense RNA was found to have antileishmanial activity; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
12097156
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania donovani
|
12596
13316
15907
26907
78691
79195
527824
528258
531885
531886
532164
532165
532166
532195
532196
532197
532198
532199
532642
532643
532644
536969
536970
544264
552236
554547
559604
561797
564379
568817
568820
568821
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
12161141
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
amastigote (BTO:0000062)
|
inferred from bioassay (ECO:0000094)
|
Leishmania donovani
|
12596
13316
15907
26907
78691
79195
527824
528258
531885
531886
532164
532165
532166
532195
532196
532197
532198
532199
532642
532643
532644
536969
536970
544264
552236
554547
559604
561797
564379
568817
568820
568821
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
12161141
|
microtubule polymerization (GO:0046785)
|
decreased (PATO:0000468)
|
in vitro (MI:0492)
|
|
inferred from specific protein inhibition (ECO:0000020)
|
Leishmania donovani
|
12596
13316
15907
26907
78691
79195
527824
528258
531885
531886
532164
532165
532166
532195
532196
532197
532198
532199
532642
532643
532644
536969
536970
544264
552236
554547
559604
561797
564379
568817
568820
568821
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
12161141
|
cell cycle arrest (GO:0007050)
|
abnormal (PATO:0000460)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania donovani
|
79195
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 483279-40-9; Drug: 483279-44-3. chemical inhibition with antimicrotubule agents leads to cell cycle arrest in cell assay; unclear as to which topoisomerase II gene/enzyme was studied. |
References: |
14645662
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
amastigote (BTO:0000062)
|
inferred from bioassay (ECO:0000094)
|
Leishmania donovani
|
79195
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 19044-89-4; Drug: 19044-94-1; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 619267-13-9; Drug: 619267-14-0; Drug: 619267-15-1; Drug: 619267-16-2; Drug: 619267-17-3; Drug: 619267-18-4; Drug: 619267-19-5; Drug: 619267-20-8; Drug: 619267-21-9; Drug: 619267-22-0; Drug: 619267-23-1; Drug: 619267-24-2; Drug: 619267-25-3; Drug: 619267-26-4; Drug: 678187-02-5; Drug: 678187-03-6; Drug: 678187-04-7; Drug: 678187-05-8; Drug: 678187-06-9; Drug: 678187-07-0; Drug: 678187-08-1; Drug: 678187-09-2; Drug: 678187-10-5; Drug: 678187-11-6; Drug: 678187-12-7; Drug: 678187-13-8; Drug: 678187-14-9. chemical inhibition with antimicrotubule agents leads to cell cycle arrest in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
15027874
|
microtubule polymerization (GO:0046785)
|
decreased (PATO:0000468)
|
in vitro (MI:0492)
|
|
inferred from specific protein inhibition (ECO:0000020)
|
Leishmania donovani
|
79195
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 19044-89-4; Drug: 19044-94-1; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 619267-13-9; Drug: 619267-14-0; Drug: 619267-15-1; Drug: 619267-16-2; Drug: 619267-17-3; Drug: 619267-18-4; Drug: 619267-19-5; Drug: 619267-20-8; Drug: 619267-21-9; Drug: 619267-22-0; Drug: 619267-23-1; Drug: 619267-24-2; Drug: 619267-25-3; Drug: 619267-26-4; Drug: 678187-02-5; Drug: 678187-03-6; Drug: 678187-04-7; Drug: 678187-05-8; Drug: 678187-06-9; Drug: 678187-07-0; Drug: 678187-08-1; Drug: 678187-09-2; Drug: 678187-10-5; Drug: 678187-11-6; Drug: 678187-12-7; Drug: 678187-13-8; Drug: 678187-14-9. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
15027874
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
amastigote (BTO:0000062)
|
inferred from bioassay (ECO:0000094)
|
Leishmania donovani
|
No drug identifiers listed for this gene.
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 902779-03-7; Drug: 908843-57-2; Drug: 908843-58-3; Drug: 908843-61-8; Drug: 908843-63-0; Drug: 908843-68-5; Drug: 908843-70-9; Drug: 908843-73-2; Drug: 908843-74-3; Drug: 908843-75-4; Drug: 908843-76-5; Drug: 908843-77-6; Drug: 908843-78-7; Drug: 908843-79-8; Drug: 908843-80-1; Drug: 908843-81-2; Drug: 908843-82-3; Drug: 908843-84-5. chemical inhibition with antimicrotubule agents leads to cell cycle arrest in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
16675220
|
microtubule polymerization (GO:0046785)
|
decreased (PATO:0000468)
|
in vitro (MI:0492)
|
|
inferred from specific protein inhibition (ECO:0000020)
|
Leishmania donovani
|
No drug identifiers listed for this gene.
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 902779-03-7; Drug: 908843-57-2; Drug: 908843-58-3; Drug: 908843-61-8; Drug: 908843-63-0; Drug: 908843-68-5; Drug: 908843-70-9; Drug: 908843-73-2; Drug: 908843-74-3; Drug: 908843-75-4; Drug: 908843-76-5; Drug: 908843-77-6; Drug: 908843-78-7; Drug: 908843-79-8; Drug: 908843-80-1; Drug: 908843-81-2; Drug: 908843-82-3; Drug: 908843-84-5. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
16675220
|
microtubule polymerization (GO:0046785)
|
decreased (PATO:0000468)
|
in vitro (MI:0492)
|
|
inferred from specific protein inhibition (ECO:0000020)
|
Leishmania tarentolae
|
79195
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 483279-44-3; Drug: 619267-15-1. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
16753146
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
amastigote (BTO:0000062)
|
inferred from bioassay (ECO:0000094)
|
Leishmania mexicana
|
449723
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 209345-04-0; Drug: 58915-19-8; Drug: 209345-05-1; Drug: 218935-77-4; Drug: 268749-50-4. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
16918078
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania infantum
|
449723
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 209345-04-0; Drug: 58915-19-8; Drug: 209345-05-1; Drug: 218935-77-4; Drug: 268749-50-4. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
16918078
|
growth (GO:0040007)
|
decreased time (PATO:0000716)
|
single cell organism (CARO:0000064)
|
promastigote (BTO:0001124)
|
inferred from bioassay (ECO:0000094)
|
Leishmania mexicana
|
449723
|
Annotator: |
aaronjr@u.washington.edu. |
Comment: |
Drug: 209345-04-0; Drug: 58915-19-8; Drug: 209345-05-1; Drug: 218935-77-4; Drug: 268749-50-4. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied. |
References: |
16918078
|